The Importance of Clinical Trials for Rare Disease Patients
September 21, 2020
How The Leukemia & Lymphoma Society’s Clinical Trial Support Center is helping cancer patients participate in clinical trials.
There are approximately 7,000 known rare diseases, but only 5% of them have an approved treatment. For patients, clinical trials are an opportunity to receive promising new therapies; however, the enrollment process can often be overwhelming to navigate.
In an effort to help patients find clinical trials, overcome barriers to enrollment, and increase awareness and education for patients and caregivers, The Leukemia & Lymphoma Society created The Clinical Trial Support Center in 2016.
The Clinical Trial Support Center (CTSC) is a free phone service that is staffed by Clinical Trial Nurse Navigators who are nurses and nurse practitioners specially trained in oncology and research. They work in collaboration with the patient’s healthcare team to educate, support, and empower the patient to be an active participant in and have control over their treatment decisions.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.